🧠 New in BJPsych: 1-year stroke risk with risperidone in dementia.
We looked across CVD subgroups ( stroke, CVD, and risk factors) to see if any group was “safer” to prescribe to.
Spoiler: there isn’t one.
📊 Infographic + link below.

www.cambridge.org/core/journal...

#Dementia #Stroke #Psychiatry

Excited to be heading to Stavanger this Sunday for Helse Stavanger’s International Research Day!

Photos from my last visit - 3yrs ago!

Sad to be missing the National Day and Eurovision there on Saturday, but thrilled to be reconnecting with collaborators.

🇳🇴🇬🇧

Just doing my bit to put Centre for Cognitive and Clinical Neuroscience @brunelpsy.bsky.social on the neuroscience connections map at #BNA2025

In Liverpool today for #BNA2025 sharing our pilot study on #psychosis mechanisms in #Alzheimer as a case study on collaboration with Medicines Discovery Catapult. Great that they're prioritising psychiatric syndromes in dementia.

Busy day this week running out SmartSocks study (testing new #healthtech for objective measurement of #agitation in #dementia). Started 3 participants in London before wrapping up for two residents in Berks after 4 weeks testing. Grateful to the care home staff for their insights!

Powered up for the last day of the conference in Sydney where I chaired the first session. Apparently açaí is a super good though maybe not when it's got that much yoghurt and syrup in top 😋

And the sunset before heading home

Very grateful to @drmoyramortby.bsky.social for making this happen 🙏🏻

Great start to the Australasian #NeuropsychiatricSyndromes Symposium yesterday in Sydney. Great to connect with people from all over the world to discuss this important topic, and have the opportunity to present myself 😁

#ANNS
@istaart.bsky.social
@brunelpsy.bsky.social

I'm in Sydney getting ready for the Australasian Neuropsychiatric Syndromes in #dementia conference.

Funded by @istaart.bsky.social this conference will bring together latest scientific advances and the applications to care delivery.

Flanked by a sizable plate of pastries before getting started with our #antipsychotics in #dementia event today. >30 attendees from social care, NHS and members of the public.

Best practice approaches for severe agitation in dementia still stimulates insightful discussion. Work here not yet done.

Very excited to be organising this event in Sydney colleagues from the US and Australia 🇦🇺🇺🇸🇬🇧

Australasian Neuropsychiatric Syndromes in #dementia Symposium 3-5th Feb 2025, Sydney, #Australia 🦘

Travel awards and registration available here:

anss.psy.unsw.edu.au

UK-based scientists: we need to talk about Italian conference catering.